Tae Hun Kim
CEO @ Humax
Tae Hun Kim is a Series B investor at Humax focused on SaaS and Hotel. Tae Hun Kim is the Chief Executive Officer at Humax.
- Total investments:
- 5
- Last investment:
- Lead investor:
- 60%
Last updated:
For AI agents: llms.txt
Industries Tae Hun Kim invests in
Stages Tae Hun Kim invests in
Countries Tae Hun Kim invests in
Contacts
| Type | Contact | Validation |
|---|---|---|
| Work email | ||
| Personal email | ||
| Work phone | ||
| Personal phone | ||
| Socials |
Investment Focus
Industry
- SaaS 1 (20%)
- Hotel 1 (20%)
- Software 1 (20%)
- Biopharma 1 (20%)
- Mobile Apps 1 (20%)
Stage
- Series B 2 (40%)
- Seed 1 (20%)
- Corporate Round 1 (20%)
- Venture - Series Unknown 1 (20%)
Country
- France 1 (20%)
- South Korea 1 (20%)
- United States 1 (20%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
AZMT
|
Hotel space development startup | Venture - Series Unknown / Jan 24, 2022 | |
LANE4
|
Lane4 develops AI-based sports analytics and motion analysis software for athletes and training environments. The company provides computer vision technology, performance tracking systems, biomechanics analysis, and data-driven coaching tools used in sports training and athletic performance evaluation. | $2.5M / Seed / Oct 21, 2021 | |
Acticor Biotech
|
Acticor Biotech is a biopharmaceutical company developing an innovative drug for the treatment in the acute phase of ischemic stroke. Acticor Biotech’s project stems from the sheer need for new therapeutic options to manage stroke. According to the World Health Organization, 15 million people suffer stroke worldwide each year. Of these, 5 milliondies and another 5 million are permanently disabled. Stroke is the third cause of death in the world and the leading cause of death among women. It is also the first cause of adult acquired disabilities resulting from the neurological damages sustained by 75% of the survivors. However, only one treatment is presently recommended by health authorities and is it estimated that only 15% of ischemic stroke patients are treated with it, with less than 40% efficacy. So while this treatment is very useful for ischemic stroke, a major need for a new treatment capable of effectively treating a majority of ischemic stroke patients remains.Acticor Biotech was founded in November 2013 and is headquartered in Paris, France. | $7.7M / Series B / Nov 06, 2019 | |
FleetUp
|
FleetUp applies big data technologies to fleet management with a patented solution that enables companies to maximize profitability, improve driver safety, and comply with current and upcoming regulations more effectively. FleetUp is offered as a Software-as-a-Service (SaaS), with hardware, cellular, and infrastructure costs bundled into theoffering with easy-to-use applications for both Android and iOS devices. | $20M / Corporate Round / Feb 27, 2018 | |
|
FleetUp
|
FleetUp applies big data technologies to fleet management with a patented solution that enables companies to maximize profitability, improve driver safety, and comply with current and upcoming regulations more effectively. FleetUp is offered as a Software-as-a-Service (SaaS), with hardware, cellular, and infrastructure costs bundled into theoffering with easy-to-use applications for both Android and iOS devices. | $5M / Series B / Apr 11, 2017 |
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
Recommended lists
FAQ
What does Tae Hun Kim invest in?
Tae Hun Kim invests primarily in SaaS, Hotel and Software startups, most often at Series B and Seed stage. Most of the 5 investments tracked by Shizune back companies in France. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Tae Hun Kim?
Public channels for Tae Hun Kim include LinkedIn. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
When did Tae Hun Kim last invest?
The most recent investment recorded for Tae Hun Kim closed in Jan 2022. Shizune tracks 5 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
